Intelligent Bio Solutions Inc.
INBS
$1.41
$0.129.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 19.98% | -30.36% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 19.98% | -30.36% | |||
| Cost of Revenue | 0.81% | -26.85% | |||
| Gross Profit | 53.03% | -35.67% | |||
| SG&A Expenses | 33.08% | -7.18% | |||
| Depreciation & Amortization | -1.05% | 1.60% | |||
| Other Operating Expenses | -29.72% | -5.95% | |||
| Total Operating Expenses | 14.28% | -20.17% | |||
| Operating Income | -12.75% | 16.91% | |||
| Income Before Tax | -13.02% | 16.25% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -13.02% | 16.25% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -2.74% | -20.65% | |||
| Net Income | -13.07% | 16.24% | |||
| EBIT | -12.75% | 16.91% | |||
| EBITDA | -14.79% | 18.77% | |||
| EPS Basic | 11.13% | 29.63% | |||
| Normalized Basic EPS | 11.12% | 29.60% | |||
| EPS Diluted | 11.13% | 29.63% | |||
| Normalized Diluted EPS | 11.12% | 29.60% | |||
| Average Basic Shares Outstanding | 27.25% | 19.02% | |||
| Average Diluted Shares Outstanding | 27.25% | 19.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||